Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus

about

Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

P2860

Q37297656-026E28E4-082D-47B2-9466-2E0B8759B306 Q38828830-D8C23C4A-778F-4C73-A83D-6EE15EF7521B

P2860

Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus

Item

http://www.wikidata.org/entity/Q42078473

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Amylin receptor: a common path ...... disease and diabetes mellitus

@en

Amylin receptor: a common path ...... disease and diabetes mellitus

@nl

type

Item

label

Amylin receptor: a common path ...... disease and diabetes mellitus

@en

Amylin receptor: a common path ...... disease and diabetes mellitus

@nl

prefLabel

Amylin receptor: a common path ...... disease and diabetes mellitus

@en

Amylin receptor: a common path ...... disease and diabetes mellitus

@nl

P1476

Amylin receptor: a common path ...... disease and diabetes mellitus

@en

P2093

Aarti Patel

http://www.w3.org/2001/XMLSchema#string

Jack H Jhamandas

http://www.w3.org/2001/XMLSchema#string

Wen Fu

http://www.w3.org/2001/XMLSchema#string

P2860

An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Mechanisms of islet amyloidosis toxicity in type 2 diabetes

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Receptor pharmacology

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2013.00042

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256076841

http://www.w3.org/2001/XMLSchema#string

P698

23966942

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

pathophysiology

P932

3744041

http://www.w3.org/2001/XMLSchema#string

Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus

about

P2860

P2860

Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932